The device, made my Respicardia, is a small implant the cardiologist places in the patient’s chest to regulate breathing during sleep. It works by activating the phrenic nerve, which tells the diaphragm to stimulate breathing.
After the procedure, 91 percent of patients experience improvements in their nighttime breathing, according to a cardiologist at Tampa General Hospital.
“The device is proven to be effective at reducing the number of times breathing stops during sleep,” said Bengt Herweg, MD, medical director of electrophysiology at the hospital and professor at USF Health Morsani College of Medicine. “Before the introduction of this device, other standard therapies for central sleep apnea such as continuous positive airway pressure machines simply were not effective.”
More articles on cardiology:
U of Arkansas for Medical Sciences names director of interventional cardiology
American Heart Association names latest addition to top mitral valve surgery program list
UPMC Pinnacle cardiologist to demonstrate TAVR procedures via live broadcasts
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
